You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
The Risk of Infection with HIV and Hepatitis B in Individuals Who Inject Steroids in England and Wales
A. C. Crampin, T. L. Lamagni, V. D. Hope, J. A. Newham, K. M. Lewis, J. V. Parry and O. N. Gill
Epidemiology and Infection
Vol. 121, No. 2 (Oct., 1998), pp. 381-386
Published by: Cambridge University Press
Stable URL: http://www.jstor.org/stable/3864565
Page Count: 6
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Data on injecting anabolic steroid users, within the national Unlinked Anonymous HIV Prevalence Monitoring Survey of injecting drug users (IDUs) were analysed to determine their risk of acquiring blood borne viruses. One hundred and forty-nine participants who had injected anabolic steroids in the previous month were identified from 1991-6, contributing 1·4% of all participation episodes in the survey. Rates of needle and syringe sharing by steroid users were low. Three of the 149 (2·0%) had anti-HBc and none had anti-HIV in their salivary specimens. The prevalence of anti-HBc in steroid injectors was significantly lower than in heroin injectors, 275/1509 (18%) (P < 0·01), or in amphetamine injectors, 28/239 (12%) (P < 0·01). The risk of blood borne virus transmission amongst these steroid injectors is low, probably due to hygienic use of injecting equipment and low levels of sharing. It is important to distinguish steroid injectors from other IDUs because they are a distinct group in terms of lifestyle and injecting practice.
Epidemiology and Infection © 1998 Cambridge University Press